Tandem Diabetes Care | TNDM - Interest Expense On Debt


Tandem Diabetes Care reported $1.15B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
Accuray USD 2.88M 72K Dec/2024
Align Technology USD 6.93M 9.11M Mar/2026
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Boston Scientific USD 96M 6M Jun/2026
Cooper Companies USD 20.9M 1.5M Mar/2026
Dexcom USD 3.1M 1.1M Mar/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
Globus Medical USD 5.44B 5.44B Mar/2026
ICU Medical USD 20.64M 21.39M Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 176M 5M Mar/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Orthofix International 4.68M 731K Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 1.15B Mar/2026
Teleflex USD 25.72M 2.43M Mar/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026